Global MRSA Drugs Market Professional Survey Report 2019
Table of Contents
Executive Summary
1 Industry Overview of MRSA Drugs
- 1.1 Definition of MRSA Drugs
- 1.2 MRSA Drugs Segment by Type
- 1.2.1 Global MRSA Drugs Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Tetracycline
- 1.2.3 Folate antagonist
- 1.2.4 Cephalosporin
- 1.2.5 Lipopeptides
- 1.2.6 Oxazolidinone
- 1.2.7 Lipoglycopeptide
- 1.3 MRSA Drugs Segment by Applications
- 1.3.1 Global MRSA Drugs Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospital
- 1.3.3 Research
- 1.3.4 Clinic
- 1.3.5 Other
- 1.4 Global MRSA Drugs Overall Market
- 1.4.1 Global MRSA Drugs Revenue (2014-2025)
- 1.4.2 Global MRSA Drugs Production (2014-2025)
- 1.4.3 North America MRSA Drugs Status and Prospect (2014-2025)
- 1.4.4 Europe MRSA Drugs Status and Prospect (2014-2025)
- 1.4.5 China MRSA Drugs Status and Prospect (2014-2025)
- 1.4.6 Japan MRSA Drugs Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia MRSA Drugs Status and Prospect (2014-2025)
- 1.4.8 India MRSA Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of MRSA Drugs
- 2.3 Manufacturing Process Analysis of MRSA Drugs
- 2.4 Industry Chain Structure of MRSA Drugs
3 Development and Manufacturing Plants Analysis of MRSA Drugs
- 3.1 Capacity and Commercial Production Date
- 3.2 Global MRSA Drugs Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of MRSA Drugs
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 MRSA Drugs Production and Capacity Analysis
- 4.2 MRSA Drugs Revenue Analysis
- 4.3 MRSA Drugs Price Analysis
- 4.4 Market Concentration Degree
5 MRSA Drugs Regional Market Analysis
- 5.1 MRSA Drugs Production by Regions
- 5.1.1 Global MRSA Drugs Production by Regions
- 5.1.2 Global MRSA Drugs Revenue by Regions
- 5.2 MRSA Drugs Consumption by Regions
- 5.3 North America MRSA Drugs Market Analysis
- 5.3.1 North America MRSA Drugs Production
- 5.3.2 North America MRSA Drugs Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America MRSA Drugs Import and Export
- 5.4 Europe MRSA Drugs Market Analysis
- 5.4.1 Europe MRSA Drugs Production
- 5.4.2 Europe MRSA Drugs Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe MRSA Drugs Import and Export
- 5.5 China MRSA Drugs Market Analysis
- 5.5.1 China MRSA Drugs Production
- 5.5.2 China MRSA Drugs Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China MRSA Drugs Import and Export
- 5.6 Japan MRSA Drugs Market Analysis
- 5.6.1 Japan MRSA Drugs Production
- 5.6.2 Japan MRSA Drugs Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan MRSA Drugs Import and Export
- 5.7 Southeast Asia MRSA Drugs Market Analysis
- 5.7.1 Southeast Asia MRSA Drugs Production
- 5.7.2 Southeast Asia MRSA Drugs Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia MRSA Drugs Import and Export
- 5.8 India MRSA Drugs Market Analysis
- 5.8.1 India MRSA Drugs Production
- 5.8.2 India MRSA Drugs Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India MRSA Drugs Import and Export
6 MRSA Drugs Segment Market Analysis (by Type)
- 6.1 Global MRSA Drugs Production by Type
- 6.2 Global MRSA Drugs Revenue by Type
- 6.3 MRSA Drugs Price by Type
7 MRSA Drugs Segment Market Analysis (by Application)
- 7.1 Global MRSA Drugs Consumption by Application
- 7.2 Global MRSA Drugs Consumption Market Share by Application (2014-2019)
8 MRSA Drugs Major Manufacturers Analysis
- 8.1 Allergan
- 8.1.1 Allergan MRSA Drugs Production Sites and Area Served
- 8.1.2 Allergan Product Introduction, Application and Specification
- 8.1.3 Allergan MRSA Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Merck
- 8.2.1 Merck MRSA Drugs Production Sites and Area Served
- 8.2.2 Merck Product Introduction, Application and Specification
- 8.2.3 Merck MRSA Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Pfizer
- 8.3.1 Pfizer MRSA Drugs Production Sites and Area Served
- 8.3.2 Pfizer Product Introduction, Application and Specification
- 8.3.3 Pfizer MRSA Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Theravance Biopharma
- 8.4.1 Theravance Biopharma MRSA Drugs Production Sites and Area Served
- 8.4.2 Theravance Biopharma Product Introduction, Application and Specification
- 8.4.3 Theravance Biopharma MRSA Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Absynth Biologics
- 8.5.1 Absynth Biologics MRSA Drugs Production Sites and Area Served
- 8.5.2 Absynth Biologics Product Introduction, Application and Specification
- 8.5.3 Absynth Biologics MRSA Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 AmpliPhi Biosciences
- 8.6.1 AmpliPhi Biosciences MRSA Drugs Production Sites and Area Served
- 8.6.2 AmpliPhi Biosciences Product Introduction, Application and Specification
- 8.6.3 AmpliPhi Biosciences MRSA Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 AstraZeneca
- 8.7.1 AstraZeneca MRSA Drugs Production Sites and Area Served
- 8.7.2 AstraZeneca Product Introduction, Application and Specification
- 8.7.3 AstraZeneca MRSA Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Basilea Pharmaceutica
- 8.8.1 Basilea Pharmaceutica MRSA Drugs Production Sites and Area Served
- 8.8.2 Basilea Pharmaceutica Product Introduction, Application and Specification
- 8.8.3 Basilea Pharmaceutica MRSA Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Baxter
- 8.9.1 Baxter MRSA Drugs Production Sites and Area Served
- 8.9.2 Baxter Product Introduction, Application and Specification
- 8.9.3 Baxter MRSA Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Cellceutix
- 8.10.1 Cellceutix MRSA Drugs Production Sites and Area Served
- 8.10.2 Cellceutix Product Introduction, Application and Specification
- 8.10.3 Cellceutix MRSA Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Cempra
- 8.12 CrystalGenomics
- 8.13 Debiopharm
- 8.14 Galapagos
- 8.15 GSK
- 8.16 KYORIN Pharmaceutical
- 8.17 Lytix Biopharma
- 8.18 Melinta Therapeutics
- 8.19 Nabriva Therapeutics
- 8.20 NovaDigm Therapeutics
9 Development Trend of Analysis of MRSA Drugs Market
- 9.1 Global MRSA Drugs Market Trend Analysis
- 9.1.1 Global MRSA Drugs Market Size (Volume and Value) Forecast 2019-2025
- 9.2 MRSA Drugs Regional Market Trend
- 9.2.1 North America MRSA Drugs Forecast 2019-2025
- 9.2.2 Europe MRSA Drugs Forecast 2019-2025
- 9.2.3 China MRSA Drugs Forecast 2019-2025
- 9.2.4 Japan MRSA Drugs Forecast 2019-2025
- 9.2.5 Southeast Asia MRSA Drugs Forecast 2019-2025
- 9.2.6 India MRSA Drugs Forecast 2019-2025
- 9.3 MRSA Drugs Market Trend (Product Type)
- 9.4 MRSA Drugs Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 MRSA Drugs Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Staphylococcus aureus is a bacteria commonly found on nose or skin of healthy people. MRSA i.e., methicillin-resistant staphylococcus aureus, is thus a type of staphylococcus aureus that is resistant to beta-lactam antibiotic called methicillin. MRSA strains do not respond to methicillin treatment. Around 1% of the population carrying staphylococcus aureus on their nose or skin are infected by MRSA. The infection causes skin and tissue infection, and is transmitted by direct skin-to-skin contact.
Methicillin-resistant Staphylococcus aureus (MRSA) is a skin infection that occurs mostly in hospitals and healthcare facilities. It is treated with commonly-used antibiotics and is highly contagious. This infection is difficult to treat because it is sometimes resistant to commonly-used antibiotics such as methicillin. As per this market research report, the aging people are highly susceptible to MRSA infections, especially in the hospital environment as their weak immune system makes them easily prone to diseases and infections.
The global MRSA Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on MRSA Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall MRSA Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of MRSA Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their MRSA Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Allergan
Merck
Pfizer
Theravance Biopharma
Absynth Biologics
AmpliPhi Biosciences
AstraZeneca
Basilea Pharmaceutica
Baxter
Cellceutix
Cempra
CrystalGenomics
Debiopharm
Galapagos
GSK
KYORIN Pharmaceutical
Lytix Biopharma
Melinta Therapeutics
Nabriva Therapeutics
NovaDigm Therapeutics
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Tetracycline
Folate antagonist
Cephalosporin
Lipopeptides
Oxazolidinone
Lipoglycopeptide
Segment by Application
Hospital
Research
Clinic
Other